According to Fortune Business Insights, the global veterinary oncology market size was valued at USD 2.90 billion in 2025 and is projected to grow from USD 3.15 billion in 2026 to USD 7.11 billion by 2034, exhibiting a CAGR of 10.70% during the forecast period. North America dominated the veterinary oncology market with a market share of 47.58% in 2025.
The market is gaining momentum as pet owners increasingly seek advanced diagnostic and treatment options for animals diagnosed with cancer. Veterinary oncology focuses on identifying, managing, and treating cancer in companion animals and other veterinary patients. Growing awareness of animal health, improvements in veterinary healthcare infrastructure, and increasing demand for specialized veterinary services are supporting the development of this market. Cancer treatment for animals increasingly involves comprehensive care plans that may include surgery, chemotherapy, radiation therapy, immunotherapy, and supportive care. Veterinary hospitals and specialty clinics are adopting advanced diagnostic technologies to identify tumors and develop personalized treatment approaches. As the human-animal bond strengthens, pet owners are more willing to explore specialized medical care to improve the health and quality of life of their animals.
Continue reading for more details:
https://www.fortunebusinessinsights.com/veterinary-oncology-market-117236
Market Segmentation
The veterinary oncology market can be segmented by animal type, cancer type, treatment, end user, and distribution channel. By animal type, the market includes companion animals and other animals, with dogs and cats representing important patient groups. Companion animals account for substantial demand because of the growing adoption of pets and the increasing attention given to their healthcare needs. Pet owners are increasingly seeking veterinary consultations when they observe unusual symptoms, contributing to demand for cancer screening and specialized treatment. Based on cancer type, the market covers lymphoma, mast cell tumors, mammary tumors, melanoma, soft tissue sarcoma, and other forms of cancer. These conditions require different diagnostic procedures and therapeutic approaches. Accurate diagnosis is important for determining the stage of disease, selecting suitable treatment options, and monitoring the response to therapy. Advances in laboratory testing, imaging technologies, and tissue analysis are helping veterinarians improve cancer identification and clinical decision-making. By treatment, the market includes surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, and other supportive approaches. Surgery is used to remove localized tumors when clinically appropriate, while chemotherapy may be recommended for cancers that require systemic treatment. Radiation therapy can help control tumors in selected cases, and immunotherapy is gaining attention for its potential to support the body's immune response against cancer. Targeted treatments and personalized care strategies are also creating opportunities for specialized veterinary oncology providers. By end user, the market includes veterinary hospitals, specialty oncology centers, veterinary clinics, and research institutions. Veterinary hospitals and specialty centers play a major role in providing advanced diagnostic services and complex cancer treatments. Distribution channels include veterinary hospitals, clinics, pharmacies, and other relevant providers that supply oncology medicines and related products.
Key Players
- PetCure Oncology
- Ethos Veterinary Health
- BluePearl Pet Hospital
- Veterinary Cancer Group
- Animal Cancer Center
- Varian Medical Systems
- Zoetis
- Elanco Animal Health
- Boehringer Ingelheim
Market Growth
The veterinary oncology market is expanding as awareness of animal cancer and the availability of specialized treatment options continue to improve. Pet owners increasingly consider companion animals important members of their households and seek medical interventions that can support longer, healthier lives. This shift is encouraging veterinary providers to expand their oncology services and invest in advanced diagnostic and treatment technologies. Technological developments are contributing to market growth by improving the detection and management of cancer in animals. Diagnostic imaging, pathology services, molecular testing, and other clinical tools can help veterinarians understand tumor characteristics and select appropriate treatment plans. Greater access to specialist consultations also enables general veterinary practitioners to refer complex cases to experienced oncology teams. The growing availability of chemotherapy, radiation therapy, surgery, and immunotherapy is broadening the range of options offered to animal patients. Veterinary facilities are also placing greater emphasis on multidisciplinary care, combining different specialties to support diagnosis, treatment planning, pain management, and follow-up care. Research into veterinary cancer biology is helping improve understanding of tumor behavior and treatment responses, supporting the development of new therapeutic approaches. Increasing investment in veterinary healthcare infrastructure is another factor supporting the market. Specialty hospitals are expanding their capabilities, while veterinary professionals are pursuing additional training in oncology. Partnerships between veterinary institutions, pharmaceutical companies, and research organizations are also helping advance treatment development and clinical knowledge. Together, these developments are strengthening the role of oncology within modern veterinary medicine.
Restraining Factors
Despite favorable growth prospects, the veterinary oncology market faces challenges related to the cost of diagnosis and treatment. Advanced procedures, specialized equipment, medicines, and repeated clinical visits can create substantial expenses for pet owners. Since veterinary cancer treatment is often paid for directly by owners, financial limitations may affect decisions about whether to pursue certain therapies. These challenges can be particularly significant when treatment requires prolonged monitoring or specialized hospital care. Limited access to veterinary oncologists is another restraint. Specialized expertise and advanced facilities may be concentrated in major urban areas, making treatment less accessible to pet owners in rural or underserved locations. Travel requirements can add financial and practical burdens, potentially delaying diagnosis and care. Differences in the availability of diagnostic services and treatment technologies can also influence the quality and range of options offered across veterinary facilities. Cancer diagnosis in animals can be complicated by symptoms that resemble other illnesses. Some tumors are detected only after the disease has progressed, which may restrict treatment choices. In addition, animals cannot describe their symptoms directly, requiring veterinarians to rely on physical examinations, diagnostic testing, and observations from owners. Concerns about treatment side effects, prognosis, and quality of life can also influence decisions regarding cancer care. Furthermore, veterinary oncology research and the development of new treatments require specialized expertise, investment, and clinical evaluation. Regulatory requirements, differences in treatment protocols, and limited awareness of available services can slow adoption in some markets. Addressing these barriers through professional training, improved access to diagnostics, and greater awareness of treatment options will be important for the industry's continued development.
Regional Analysis
North America holds a leading position in the veterinary oncology market, supported by established veterinary healthcare infrastructure, growing pet ownership, and strong awareness of advanced animal medical services. The region benefits from the presence of specialty veterinary hospitals, trained oncology professionals, diagnostic facilities, and providers offering comprehensive cancer treatment. Pet owners' willingness to pursue specialized care also supports demand for oncology consultations, diagnostic testing, surgery, chemotherapy, and radiation therapy. Ongoing research and the availability of advanced veterinary technologies further strengthen the regional market. Europe represents an important market, supported by established animal healthcare systems, increasing attention to pet welfare, and demand for specialized veterinary services. Veterinary hospitals and clinics are expanding their diagnostic capabilities, while awareness of cancer treatment options continues to develop among pet owners. Research collaborations and improvements in veterinary education may further support the adoption of advanced oncology practices. Asia Pacific is expected to offer growth opportunities as pet ownership rises and veterinary healthcare services continue to develop. Increasing awareness of animal welfare, improving access to veterinary hospitals, and greater investment in diagnostic and treatment facilities are creating favorable conditions for market expansion. However, differences in access to specialist care and affordability may influence adoption across individual countries. Latin America is gradually developing its veterinary oncology capabilities as pet owners and veterinary professionals become more aware of specialized cancer care. Growth opportunities are associated with improvements in veterinary infrastructure, access to diagnostic technologies, and the expansion of professional services. Market development may vary depending on economic conditions and the availability of trained specialists. The Middle East and Africa market is supported by increasing interest in companion animal healthcare and gradual improvements in veterinary service availability. Specialized treatment remains less accessible in some areas, creating opportunities for investment in veterinary hospitals, professional education, and diagnostic infrastructure. Greater awareness among pet owners and stronger access to specialized veterinary care could support the region's future development.
Comments